Oxidative and nitrosative stress biomarkers in chronic schizophrenia-Reference-Cited by-同舟云学术

Oxidative and nitrosative stress biomarkers in chronic schizophrenia

Published:2017-07 Issue: Volume:253 Page:43-48
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Boll Karine Maria,Noto Cristiano,Bonifácio Kamila Landucci,Bortolasci Chiara Cristina,Gadelha Ary,Bressan Rodrigo Affonseca,Barbosa Décio Sabbatini,Maes Michael,Moreira Estefania Gastaldello

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference53 articles.

1. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study;Albayrak;Prog. Neuro-Psychopharmacol. Biol. Psychiatry,2013

2. Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia;Anderson;Prog. Neuro-Psychopharmacol. Biol. Psychiatry,2013

3. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am. J. Psychiatry,2005

4. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia;Asevedo;J. Psychiatr. Res.,2013

5. Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo;Batra;Endocrinology,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Action of Silymarin against Ketamine-induced Schizophrenia in Male Mice: Insight into the Biochemical and Molecular Mechanisms of Action;Journal of Psychiatric Research;2024-09

2. Associations between residential environments and late-onset schizophrenia in UK Biobank: Interaction with genetic risk factor;Schizophrenia Research;2024-08

3. Are Advanced Oxidation Protein Products (AOPPs) Levels Altered in Neuropsychiatric Disorders? An Integrative Review;Molecular Neurobiology;2024-04-06

4. Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia;BMC Psychiatry;2024-04-02

5. The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice;Molecules;2024-01-29